Clinical Trial Update: Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer [NA]

View source ↗

Summary

A recruiting clinical trial is evaluating the safety and efficacy of the BGT007H cell therapy for patients with relapsed or refractory pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• BGT007H cell therapy

Snippet

Sponsor: RenJi Hospital | Conditions: Tumor Pancreas | NA | Status: RECRUITING